CarbGeM to Exhibit at MEDICAL FAIR THAILAND 2025

CarbGeM to Exhibit at MEDICAL FAIR THAILAND 2025
CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”) will participate as a co-exhibitor at the Kobe Biomedical Innovation Cluster booth during MEDICAL FAIR THAILAND 2025, to be held from September 10 (Wed) to 12 (Fri), 2025 in Bangkok, Thailand.
MEDICAL FAIR THAILAND is one of the most prominent international medical device and healthcare trade fairs in the Asia region, bringing together medical device manufacturers, research institutions, government organizations, and distributors from around the world to showcase the latest medical and research technologies.
________________________________________

Exhibition Overview

• Exhibition Title: MEDICAL FAIR THAILAND 2025
• Dates: September 10 (Wed) – September 12 (Fri), 2025
• Venue: BITEC (Bangkok International Trade & Exhibition Center, Thailand)
• Organizer: Messe Düsseldorf Asia
• Official Website: (リンク »)
________________________________________

CarbGeM’s Exhibits

Life Science DX/AI Solutions

A comprehensive solution suite built upon practical expertise and know-how gained from developing DX/AI-enabled medical devices in the diagnostic field, now expanded to the broader life science industry. The solutions address a wide range of technical needs—including image analysis, big data analytics, machine learning, and regulatory compliance—while supporting diagnostic assistance, research efficiency, and commercialization.
More details: (リンク »)


Automated Gram Stainer (Non-Medical Device) PoCGS®-iE

A compact automated Gram staining system that completes fixation to staining in approximately five minutes. It allows users to configure and register individual conditions such as reagent application time, volume, and decolorization steps. By automating the Gram staining process, which requires specialized expertise, the device improves efficiency and standardization, reduces working time, and contributes to addressing labor shortages and improving work environments.
More details: (リンク »)


Microorganism Estimation Support AI Software (Non-Medical Device) BiTTE®-iE

A tool that enables high-precision microorganism estimation through AI-based image analysis of Gram-stained images. Built on an AI recognition model trained with Gram-stained images and culture-confirmed microbial species, it estimates microorganisms across three classification layers: morphology, species, and intermediate categories. By simply mounting a smartphone onto a microscope and uploading captured Gram-stained images to the software, users can obtain classification results within about 10 seconds.

More details: (リンク »)


Cloud-Based AI Image Analysis Platform CarbConnect®

A cloud platform that enables image data analysis and sharing in the medical and life science fields. Researchers and experts around the world can access the platform to analyze and discuss data in real time. As a “crossroad of knowledge,” CarbConnect® fosters international open innovation.

More details: (リンク »)

________________________________________

Through this exhibition, CarbGeM aims to widely introduce the potential applications of DX/AI technologies in the Asian market and further advance international collaboration with medical and research institutions.
________________________________________

About CarbGeM Inc.

CarbGeM drives innovation in the life sciences field through advanced technologies, including regulatory approval of software as a medical device (SaMD). The company promotes diagnostic support, research efficiency, and the standardization and automation of quality management. CarbGeM addresses pressing societal challenges such as shortages of skilled professionals and disparities in regional healthcare by delivering accurate and rapid results that support clinical and industrial settings.

By leveraging AI technologies and digital platforms, CarbGeM strengthens collaboration among researchers and healthcare professionals, aiming to contribute to the resolution of global issues such as antimicrobial resistance (AMR). The company has received numerous awards, including the Tokyo Social Innovation Tech Award 2024 hosted by the Tokyo Metropolitan Government. Through open innovation with leading domestic and international research institutions, industry, government, and academia, CarbGeM continues to advance the co-creation of the future of medicine and research.

• Headquarters: 1-5-13 Jinnan, Shibuya-ku, Tokyo
• CEO: Masakazu Nakajima
• Website: (リンク »)